Objective: The regulation of pulmonary prostacyclin synthesis is not completely understood. We tested the hypothesis that prostacyclin production is predominantly stimulated by hemodynamic factors, such as increased shear-stress, and is thus increased in rats with chronic hypoxic pulmonary hypertension. Methods: To this end, we determined pulmonary prostacyclin synthase (PGIS) gene expression, circulating levels of the stable prostacyclin metabolite 6-keto prostaglandin F (6-keto-PGF ), pulmonary endothelin (ET)-1 gene 1a 1a
Introduction
Prostacyclin, a major arachidonic acid metabolite in the vascular wall, is a potent endogenous inhibitor of platelet Chronic pulmonary hypertension is characterized by an aggregation, smooth muscle cell proliferation and vasoconelevation in pulmonary vascular tone and the development striction [1, 2] . The final committed step in the synthesis of of pulmonary vascular remodeling resulting in increased prostacyclin, the conversion of prostaglandin H2 to prospulmonary vascular resistance, often leading to right tacyclin, is catalyzed by the membrane-bound enzyme ventricular failure and death. A growing body of evidence prostacyclin synthase (PGIS), which is constitutively suggests that alterations in the production of endothelialexpressed in vascular endothelial and smooth muscle cells derived vasoactive factors, such as nitric oxide (NO), [3] . Continuous intravenous infusion of prostacyclin has endothelin (ET)-1 and prostacyclin contribute significantly been shown to be effective in the treatment of various to the development of the disease.
forms of pulmonary hypertension [4] . In addition, it has been demonstrated that transgenic mice with an overexpression of pulmonary PGIS are protected against the *Corresponding author. Tel.: 149-941-944-7281; fax: 149-941-development of chronic hypoxic pulmonary hypertension 9447282 . E-mail address: friedrich.blumberg@klinik.uni-regensburg.de (F.C. Blumberg) .
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[5], and that augmentation of pulmonary prostacyclin did not exceed 0.3%. Normoxic rats were housed in production by tracheal gene transfer of human PGIS identical cages adjacent to the chambers in the same room attenuates pulmonary hypertension in monocrotalinewhile breathing room air. Animal experiments were contreated rats [6] . ducted according to the Guide for the Care and Use of Only limited data exist regarding the endogenous proLaboratory Animals published by the US National Instiduction of prostacyclin in pulmonary hypertension. In tutes of Health (NIH Publication No. 85-23, revised 1996) humans with severe pulmonary hypertension, prostacyclin and German laws on the protection of animals. production seems to be decreased as indicated by reduced 24-h urinary excretion of the stable prostacyclin metabolite 2.2. Hemodynamic measurements 2,3-dinor-6-keto prostaglandin F and reduced pulmonary 1a PGIS gene expression [7, 8] . In accordance with these Systolic blood pressure was measured in all rats the day reports in advanced disease, Badesch et al. reported before the end of the study period under prewarmed and declined prostacyclin synthesis in neonatal calves with normoxic conditions by the tail-cuff method (BP monitor severe pulmonary hypertension [9] .
TSE 210 000-2T, Technical and Scientific Equipment, However, in contrast, Shaul et al. demonstrated that Kronberg, Germany). prostacyclin production is enhanced in endothelial and
At the end of the study period, right ventricular systolic smooth muscle cells of pulmonary arteries derived from pressure (RVSP) was measured in all rats with a closedrats with chronic hypoxic pulmonary hypertension [10] .
chest technique, as previously described [15] . For this Moreover, Voelkel et al. [11] described an increase in purpose, each rat was taken from its cage and immediately prostacyclin formation in isolated rat lungs during vasanesthetized with thiopental (50 mg / kg, i.p.). Via a nose oconstriction, corroborating the finding that shear-stress is mask the lungs were artificially ventilated with room air an important stimulus for both prostacyclin formation and using a rodent respirator (Animal Respirator, Technical PGIS gene expression in cultured endothelial cells [12] .
and Scientific Equipment, Kronberg, Germany). The right Based on these latter observations, we speculated that jugular vein was cannulated and a catheter was introduced pulmonary prostacyclin production is primarily regulated into the right ventricle. The system was filled and flushed by hemodynamic factors, and is thus increased in rats with with ,2 ml of heparin solution (1000 I.U. / ml). After chronic hypoxic pulmonary hypertension. To test this reaching a stable hemodynamic condition, RVSP was hypothesis and to examine the role of NO and ET-1 in this measured using a pressure transducer (P23Db, Statham regulatory process, we determined pulmonary PGIS Labs., Hatorey, Puerto Rico). mRNA and circulating 6-keto prostaglandin F (6-keto1a PGF ) levels, as well as pulmonary ET-1 mRNA and 2.3. Organ sampling 1a ET-1 plasma levels in chronic hypoxic rats in the presence or absence of either the NO donor molsidomine (MD) or Immediately following the hemodynamic measurements the ET-A receptor antagonist LU135252 (LU), both of the animals were killed by decapitation. Blood was colwhich have previously been shown to ameliorate exlected from the carotid arteries. Heart and lungs were perimental pulmonary hypertension in rats [13, 14] .
removed and the pulmonary artery was perfused with 0.9% saline until the obtained solution was clear. The right lung was dissected and frozen in liquid nitrogen until RNA 2. Methods extraction. For morphological measurements, the left lung was fixed in the distended state by the infusion of 10% 2.1. Experimental groups and chronic hypoxia buffered formalin into the pulmonary artery and trachea at 10 and 25 cm H O perfusion pressure, respectively, for 3 2 Adult male Wistar rats (Charles River Labs., Sulzfeld, min and kept in 10% buffered formalin for at least 24 h. Germany; 250-300 g) were randomly assigned to one of Lungs were then embedded in paraffin and 5-mm sections the following groups: 4 weeks of normoxia (Norm, n510), were stained with Van Gieson's stain. 4 weeks of hypoxia (4wHyp, n510), or 4 weeks of hypoxia receiving either LU (50 mg / kg / day; Knoll, 2.4. Light microscopic analysis of pulmonary arteries Mannheim, Germany, 4wHyp1LU, n510) or MD (15 mg / kg / day; Hoechst Marion Roussel, Bad Soden, GerMicroscopic slices were analyzed using a computerized many, 4wHyp1MD, n510) in the drinking water. Rats morphometric system (ANALYSIS, Soft-Imaging Software, were exposed to normobaric hypoxia (10% O -rest N ) in Munster, Germany). Total vessel area was defined as the 2 2 separate transparent plastic chambers as previously dearea within the elastica externa. Medial area was defined as scribed [15] . Relative humidity within the chamber was the area between the lamina elastica externa and the lamina kept at ,70% with anhydrous CaSO . Boric acid was used elastica interna. Pulmonary arteries with an external diam-2 to keep NH levels in the chamber at a minimum. The eter ranging between 30 and 100 mm were examined.
3 percentage of CO in the chamber was measured daily and Thirty arteries per animal were measured. The average of three measurements obtained from each artery was used Vaterstetten, Germany. Linearization with EcoRV and in for calculations as described previously [13] . Slides were vitro transcription with SP6 RNA polymerase yielded a analyzed by two observers who were blinded for the 318-bp long antisense transcript which was used in the modality of treatment. Variability was assessed by performRNase protection assay. ing repeated analyses and was calculated as 4% (intraAfter autoradiography of the dried gel, counts per observer) and 6% (interobserver).
minute (cpm) of the protected fragments were detected and counted using a phosphoimager (Instant Imager 2024, 2.5. RNA extraction Canberra-Packard, Dreieich, Germany). tated with an equal volume of isopropanol at 220 8C for at diketo-13,14-dihydro-PGF 0.12%; other prostaglandins 1a least 1 h. The resulting RNA pellets were resuspended in ,0.01%). ET-1 levels were measured with a commercially 0.5 ml of solution D, again precipitated with an equal available radioimmunoassay (Amersham, UK). Plasma volume of isopropanol at 220 8C. Pellets were finally extraction was performed with a standard technique as dissolved in diethylpyrocarbonate treated water and stored described elsewhere [19] . at 280 8C until further processing [16] .
Statistical analysis 2.6. Quantification of ET-1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and PGIS mRNA
All values are presented as means6S.D. if not stated otherwise. We compared the variations among the different Endothelin-1 mRNA was measured by RNase protection study groups in respect to hematocrit, hemodynamics, assay as described previously [17] . The plasmid containing pulmonary vascular remodeling, pulmonary PGIS gene the antisense sequence of ET-1 was a friendly gift of Mr.
expression, 6-keto-PGF plasma levels, lung ET-1 gene 1a
Peter Ratcliffe, Oxford, UK. It yields a 154-bp long expression and plasma levels. Data were analyzed by an a protected fragment in the RNase protection assay. A 20-mg priori ANOVA (for planed comparisons) using SPSS 10.0 amount of total lung RNA was used for endothelin assays.
software (SPSS, Chicago, IL, USA). A value of P,0.05 For normalization of the endothelin values we conwas considered significant. structed a transcription vector producing a 341-bp antisense RNA fragment of rat GAPDH [18] . To minimize discrepancies due to RNA quantity and quality each 3. Results assayed probe was coanalyzed for GAPDH mRNA. The vector producing the GAPDH antisense fragment used in 3.1. Hematocrit and hemodynamic measurements RNase protection assay was cloned as follows. The PCR derived fragment resulting from amplification with the Hematocrit was significantly elevated in hypoxic aniupstream (59-acctgaagggtggtgcca-39; binding at bp 356-mals and was not changed by LU or MD (Table 1) . 373) and downstream primers (59-tcagctctgggatgacct-39;
Chronic hypoxia resulted in pulmonary hypertension as binding at bp 680-697) was cloned in the transcription indicated by a significant increase in RVSP, but did not vector pGEM 4Z (Pharmacia, Heidelberg, Germany). A alter systolic blood pressure. LU and MD significantly 1-mg amount of total lung RNA was used for GAPDH reduced RVSP as compared to rats exposed solely to assays.
hypoxia. Systolic blood pressure was not significantly For quantification of PGIS gene expression a 318-bp affected by the drugs (Table 1) . long PCR derived cDNA fragment of rat prostacyclin synthase was amplified (accession number U53855; upstream primer bp241-bp258; downstream primer bp541-3.2. Morphological studies bp558). The PCR insert was cloned into the EcoRI cloning site of the transcription vector pCR TopoII using the PCR Medial cross-sectional vascular wall area of the small Topo cloning kit (Invitrogen, Groningen, The Netherpulmonary arteries increased significantly in chronically lands). The correctness of the constructed plasmid was hypoxic rats. LU and MD attenuated the medial vascular confirmed by sequence analysis done by Fa. Sequiserve, wall hypertrophy during hypoxia (Table 1) . 
Pulmonary GAPDH, PGIS and ET-1 mRNA expression
Pulmonary GAPDH mRNA expression did not change significantly in the different study groups (Fig. 1) . After 4 weeks of hypoxia, levels for pulmonary PGIS mRNA 3.3. 6-Keto-PGF and ET-1 plasma levels 1 a Hypoxia was accompanied by an increase in 6-keto-PGF and ET-1 plasma levels. LU and MD both reduced 1a 6-keto-PGF levels. In contrast, MD reduced ET-1 plas1a ma levels, whereas LU did not modify this parameter (Table 1) . expression presented as percentage of normoxic controls (5100%) in normoxic controls (Norm), in rats exposed to 4 weeks of hypoxia (4wHyp), and in rats exposed to 4 weeks of hypoxia receiving either LU 135252 (4wHyp1LU) or molsidomine (4wHyp1MD). Values are presented as mean6S.E.M.; *, P,0.05 vs. Norm; [, P,0.05 vs. 4wHyp. showing pulmonary endothelin (ET)-1 mRNA expression in normoxic normoxic controls (a), in rats exposed to 4 weeks of hypoxia (b), and in controls (a), in rats exposed to 4 weeks of hypoxia (b), and in rats rats exposed to 4 weeks of hypoxia receiving either LU 135252 (c) or exposed to 4 weeks of hypoxia receiving either LU 135252 (c) or molsidomine (d); 30 mg of total lung RNA were used for the assay. molsidomine (d); 20 mg of total lung RNA were used for the assay.
This hypothesis is in accordance with the findings of Voelkel et al. [11] who demonstrated that the increase in prostacyclin synthesis in isolated rat lungs is linked to vasoconstriction and not to hypoxia, and Okahara et al. [12] who reported that shear-stress is a potent stimulus of PGIS gene expression and prostacyclin formation in vascular endothelial cells. Consistent with the finding that drug treatment did not completely prevent the development of pulmonary hypertension and vascular remodeling, lung PGIS mRNA as well as circulating 6-keto-PGF levels 1a tended to increase in both treatment groups as compared to normoxic controls. However, this increase did not reach statistic significance. Nitric oxide has also been reported to induce prostacyclin formation in cultured endothelial cells in vitro [21, 22] . Nevertheless, in contrast to these in vitro reports, presented as percentage of normoxic controls (5100%) in normoxic treatment with MD, which has previously been shown to controls (Norm), in rats exposed to 4 weeks of hypoxia (4wHyp), and in act primarily through the liberation of NO [23] , reduced rats exposed to 4 weeks of hypoxia receiving either LU 135252 PGIS gene expression and 6-keto-PGF plasma levels in (4wHyp1LU) or molsidomine (4wHyp1MD [26] . Thus, it might influence this gene expression significantly (Figs. 4 and 5) .
be that prostacyclin serves as a compensatory mediator that counteracts the hypoxia-induced NO deficiency. Such a theory could also explain why exogenously administered 4. Discussion NO reduces the formation of prostacyclin in these animals. However, we did not investigate these possibilities in the The current study demonstrates for the first time that current study. pulmonary PGIS gene expression and 6-keto-PGF plasEndothelin is another powerful vasoactive factor which 1a ma levels are increased in rats with chronic hypoxic seems to play a pivotal role in the pathogenesis of various pulmonary hypertension, and that this increase is primarily forms of pulmonary hypertension. In accordance with the result of the hemodynamic changes associated with the previous studies, we found increased pulmonary ET-1 development of pulmonary hypertension, while hypoxia, mRNA and plasma levels in rats exposed to chronic NO and ET-1 are less important factors for the upregulahypoxia [13, 27, 28] . Nevertheless, the role of ET-1 in the tion of prostacyclin synthesis in chronic hypoxic rat lungs pulmonary circulation is complicated by the fact that it acts in vivo. Our findings corroborate and extend previous through two distinct receptor subtypes mediating opposite results by Shaul et al. who reported increased prostacyclin effects. The vasoconstrictive and proliferative actions of formation in lung endothelial and vascular smooth muscle ET-1 are mediated through activation of the ET-A receptor cells of rats exposed to chronic hypoxia [10] . However, the on the vascular smooth muscle cell [29, 30] , whereas mechanisms for the regulation of prostacyclin synthesis stimulation of the endothelial ET-B receptor induces have not yet been completely elucidated.
vasodilation via the release of NO and prostacyclin [31] . Reduced oxygen tension has been described as an Both receptor subtypes are upregulated in chronic hypoxic independent stimulus for the upregulation of prostacyclin rat lungs [28] . Therefore, it could be that the increase in production in dog lungs in vitro [20] . Nevertheless, the prostacyclin synthesis observed in hypoxic animals is the observation that the increase in prostacyclin formation in result of an increased ET-1 mediated activation of the our experiments is ameliorated during the treatment of ET-B receptor. However, the finding that treatment of pulmonary hypertension, despite continuing hypoxic expopulmonary hypertension with the highly selective ET-A sure, indicates that hemodynamic factors such as increased receptor antagonist LU [14] reduced pulmonary prospulmonary artery pressure or shear-stress associated with tacyclin synthesis despite increased ET-1 levels, makes hypoxia-induced pulmonary vasoconstriction, and not such a mechanism rather unlikely. hypoxia per se are crucial for the induction of pulmonary Moreover, our findings are in accordance with studies PGIS gene expression in chronic hypoxic rat lungs in vivo.
using isolated rat lung and rabbit kidney [32] , and isolated rat aortic rings [33] , demonstrating that the ET-1 induced Whether these contradictory findings are species-dependent increase in prostacyclin formation could be attenuated by or due to differences in the pathogenesis or severity of the ET-A receptor antagonists, whereas selective ET-B redisease and the degree of endothelial destruction requires ceptor agonists and ET-B receptor antagonists did not further investigation. However, our results show that influence prostacyclin release. Since ET-A receptor anpulmonary hypertension is not inevitably associated with tagonists also reduced the ET-1-induced vasoconstriction reduced prostacyclin formation. in the isolated organ preparations, and the ET-1-induced
In conclusion, our findings demonstrate that pulmonary release of prostacyclin in isolated aortic rings was meprostacyclin production is increased in rats with chronic diated by an influx of calcium, these studies are, furtherhypoxic pulmonary hypertension predominantly due to more, in good agreement with our hypothesis that an hemodynamic factors, while hypoxia, NO and ET-1 per se increase in vascular tone is crucial for the stimulation of seem to be less important stimuli, that the upregulation prostacyclin formation.
may serve as a compensatory mechanism to partially Nevertheless, since it has been reported by Grunstein et counteract the elevation in pulmonary vascular tone, and al. that ET-1 reduced the acetylcholine-induced contraction that both NO donors and ET-A receptor antagonists reduce of isolated tracheal muscle segments of the rabbit probably the formation of prostacyclin probably through their due to an ET-A receptor mediated increase in prostacyclin beneficial effects on pulmonary hemodynamics. production [34], we cannot exclude that prostacyclin formation is in part stimulated by an ET-A receptor pathway independently from smooth muscle cell contracAcknowledgements tion. However, further study is needed to elucidate such possibilities.
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